Par-4 Down-regulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy Alvarez, James V. , Pan, Tien-chi , Ruth, Jason , Feng, Yi ... - - Cancer Cell - 2013 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-150007
Activating Mutations in PIK3CA or AKT1 in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657) Boudreau, A. , Yau, C. , Petrillo, L. , Stemke-Hale, K. , Mills, G. ... - SABCS - Cancer Res. - 2011 Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007
Comparison of Residual Cancer Burden, American Joint Committee on Cancer staging and Pathologic Complete Response in Breast Cancer after Neoadjuvant Chemotherapy: Results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) Campbell, Jeffrey I. , Yau, Christina , Krass, Polina , Moore, Dan ... - - Breast Cancer Res. Treat. - 2017 Manuscript - Secondary - Primary - Breast - CALGB-150007
The Prognostic Implications of Macrophages Expressing Proliferating Cell Nuclear Antigen in Breast Cancer Depend on Immune Context Campbell, Michael J. , Wolf, Denise , Mukhtar, Rita A. ... - - PLoS ONE - 2013 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007
Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657) Clark, Amy S , Chen, Jinbo , Kapoor, Shiv , Friedman, Claire ... - - Cancer Med - 2014 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007
Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657) Cureton, Elizabeth L. , Yau, Christina , Alvarado, Michael D. ... - - Ann. Surg. Oncol. - 2014 Manuscript - Secondary - Primary - Breast - CALGB-150007
Loss of p27 expression and response to neoadjuvant chemotherapy: Results from the I-SPY Trial (CALGB150007/150012, ACRIN6657) Demichele, A. , Dunn, L. , Gimotty, P. , Livasy, C. , Perou, C. ... - ASCO - J Clin Oncol - 2009 Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007
Comparison of community and central Her2 assessment on outcome of neoadjuvant chemotherapy in the I-SPY trial (CALGB 150007/150012, ACRIN 6657) Demichele, A. , Yau, C. , Zhu, J. , Wuhfkuhle, J. , Lenburg, M. E. ... - SABCS - Cancer Res. - 2011 Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657 Esserman, L. J. , Berry, D. A. , Demichele, A. , Carey, L. ... - - J. Clin. Oncol. - 2012 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012 , ACRIN-6657
Breast cancer molecular profiles and tumor response of neoadjuvant doxorubicin and paclitaxel: The I-SPY Trial (CALGB 150007/150012, ACRIN 6657) Esserman, L. J. , Perou, C. M. , Cheang, M. , Demichele, A. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) Esserman, Laura J. , Berry, Donald A. , Cheang, Maggie C. U. ... - - Breast Cancer Res. Treat - 2012 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007
Sentinel node biopsy performed in the neoadjuvant setting for Breast Cancer: Results from the CALGB 150007 & 150012/ACRIN 6657 I-SPY TRIAL Gomez, R. , Zakhireh, J. , Moore, D. , Demichelle, A. , Przewoznik, J. ... - SABCS - Cancer Res. - 2009 Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007
Genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer Hatzis, Christos , Pusztai, Lajos , Valero, Vicente ... - - JAMA - 2011 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007
Comparison of MRI endpoints for assessing breast cancer response to neoadjuvant treatment: preliminary findings of the American College of Radiology Imaging Network (ACRIN) trial 6657 Hylton, N. M. , Blume, J. , Bernreuter, W. , Pisano, E. , Rosen, M. ... - - Cancer Res. - 2009 Abstract - Primary - Preliminary - Breast - CALGB-150007
MRI Assessment of Breast Cancer Response to Neoadjuvant Chemotherapy: Preliminary Findings of the American College of Radiology Imaging Network (ACRIN) Trial 6657 Hylton, N. M. , Blume, J. , Bernreuter, W. , Pisano, E. , Rosen, M. ... - RSNA - Radiological Society of North America 94th Scientific Assembly and Annual Meeting - 2008 Abstract - Primary - Preliminary - Breast - CALGB-150007
MRI tumor volume for predicting response to neoadjuvant chemotherapy in locally advanced breast cancer: Findings from ACRIN trial 6657/CALGB 150007 Hylton, N. M. , Blume, J. , Gastonis, C. , Gomez, R. , Bernreuter, W. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary - Primary - Breast - ACRIN-6657 , CALGB-150007
Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL Hylton, Nola M. , Blume, Jeffrey D. , Bernreuter, Wanda K. ... - - Radiology - 2012 Manuscript - Primary - Primary - Breast - CALGB-150007
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL Hylton, Nola M. , Gatsonis, Constantine A. , Rosen, Mark A. ... - - Radiology - 2016 Manuscript - Secondary - Primary - Breast - CALGB-150007
Multicenter I-SPY 1 TRIAL (CALGB 150007/150012): Breast cancer stem cells are associated with intrinsic chemoresistance and worse survival Landis, M. , Yau, C. , Neumeister, V. , Rimm, D. , Esserman, L. ... - - Cancer Res. - 2012 Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012
RANK expression in primary tumor tissue at the time of diagnosis correlates with risk of subsequent bone metastases in the I-SPY 1 trial (CALGB 150007/150012; ACRIN 6657) Li, J. , Yau, C. , Campbell, M. , Park, J. W. ... - SABCS - Cancer Res. - 2011 Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007
Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL Li, Wen , Arasu, Vignesh , Newitt, David C. , Jones, Ella F. ... - - Tomography - 2016 Manuscript - Secondary - Primary - Breast - ACRIN 6657 , CALGB-150007
Detection of locally advanced breast cancer in the I-SPY TRIAL (CALGB 150007/150012, ACRIN 6657) in the interval between routine screening Lin, C. , Moore, D. , Demichele, A. , Ollila, D. W. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial) Lin, Cheryl , Buxton, Meredith Becker , Moore, Dan , Krontiras, Helen ... - - Breast Cancer Res. Treat. - 2012 Manuscript - Secondary - Primary - Breast - CALGB-150007 , CALGB-150012
Semi-quantitative protein analysis of HER2 and ER levels in human breast cancer reveals broad expression ranges within HER2+ and ER+ phenotypes Liotta, L. , Pierobon, M. , Wulfkuhle, J. , Laird, J. , Livasy, C. ... - ASCO - J. Clin. Oncol. - 2009 Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer Lips, Esther H. , Mukhtar, Rita A. , Yau, Christina ... - - Breast Cancer Res. Treat. - 2012 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007
Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response Magbanua, Mark Jesus M. , Wolf, Denise M. , Yau, Christina ... - - Breast Cancer Res - 2015 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007
MRI phenotype and tumor subtype affect breast conservation eligibility and MRI accuracy in the I-SPY 1 trial Mukhtar, R. A. , Hylton, N. M. ... - - Cancer Res. - 2011 Abstract - Secondary - Primary - Breast - CALGB-150007
Lobular breast cancer and NAC: Combined results from the NKI and I-SPY 1 trial Mukhtar, R. A. , Lips, E. , Wesseling, J. , Livasy, C. , Yau, C. ... - - Cancer Res. - 2011 Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007
PCNA+ tumor associated macrophages are associated with M1 and M2 gene expression, and confer poor prognosis in the absence of anti-tumor immune environment Mukhtar, R. A. , Wolf, D. , Tandon, V. , Zhu, J. , Lenburg, M. ... - - Cancer Res. - 2011 Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007
Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) Mukhtar, Rita A. , Yau, Christina , Rosen, Mark , Tandon, Vickram J. ... - - Ann. Surg. Oncol - 2013 Manuscript - Secondary - Primary - Breast - CALGB-150007
Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL Olshen, Adam , Wolf, Denise , Jones, Ella F. , Newitt, David ... - - J Med Imaging (Bellingham) - 2018 Manuscript - Secondary-not-in-original - Primary - Breast - CALGB-150007
Receptor Activator of Nuclear Factor Kappa B (RANK) Expression in Primary Breast Cancer Correlates with Recurrence Free Survival and Development of Bone Metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657) Vidula, Neelima , Yau, Christina , Li, Jiali , Esserman, Laura J. ... - - Breast Cancer Res. Treat. - 2017 Manuscript - Secondary - Primary - Breast - CALGB-150007
Androgen receptor gene expression in primary breast cancer Vidula, Neelima , Yau, Christina , Wolf, Denise ... - - NPJ Breast Cancer - 2019 Manuscript - Secondary-not-in-original - Primary - Breast - CALGB-150007
Patient-specific integrative pathway analysis using PARADIGM identifies key activities in I-SPY 1 breast cancer patients (CALGB 150007/150012; ACRIN 6657) Wolf, D. , Yau, C. , Benz, S. , Vaske, C. , Stuart, J. , Roy, R. ... - SABCS - Cancer Res. - 2011 Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007
Gene expression changes associated with response to neoadjuvant chemotherapy are observed early in treatment: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) Wolf, D. , Yau, C. , Magbanua, M. , Boudreau, A. , Davis, S. , Haqq, C. ... - - Cancer Res. - 2012 Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012
Discovery of a new phosphoHER2+/FISH- molecular subtype of human breast cancer by functional pathway mapping Wulfkuhle, J. , Pierobon, M. , Laird, J. , Espina, V. , Liotta, L. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007
Protein pathway activation mapping of I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with HR+/HER2– tumors Wulfkuhle, J. , Yau, C. , Gallagher, R. , Wolf, D. , Calvert, V. ... - SABCS - Cancer Res. - 2012 Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012
Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping Wulfkuhle, Julia D. , Berg, Daniela , Wolff, Claudia , Langer, Rupert ... - - Clin. Cancer Res. - 2012 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007
